Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-10-24

FDA Approved: FROVATRIPTAN SUCCINATE — Supplemental Application (Glenmark Pharmaceuticals Inc., USA)

View source ↗

Summary

The FDA approved a supplemental application for frovatriptan succinate from Glenmark Pharmaceuticals Inc., USA.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Frovatriptan succinate (FROVATRIPTAN SUCCINATE)

Snippet

SUPPL AP for FROVATRIPTAN SUCCINATE (FROVATRIPTAN SUCCINATE)